A phase Ia/Ib, dose-escalation/expansion study of the MDM2-p53 antagonist BI 907828 in patients (pts) with advanced/metastatic sarcoma Meeting Abstract


Authors: Gounder, M.; Patel, M. R.; Yamamoto, N.; Bauer, T. M.; Laurie, S.; Perez-Pitarch, A.; Geng, J.; Cheng, J.; Lahmar, M.; Lorusso, P.
Abstract Title: A phase Ia/Ib, dose-escalation/expansion study of the MDM2-p53 antagonist BI 907828 in patients (pts) with advanced/metastatic sarcoma
Meeting Title: ESMO Congress 2021
Journal Title: Annals of Oncology
Volume: 32
Issue: Suppl. 5
Meeting Dates: 2021 Sep 16-21
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2021-09-01
Start Page: S1124
End Page: S1125
Language: English
ACCESSION: WOS:000700527703095
DOI: 10.1016/j.annonc.2021.08.878
PROVIDER: wos
Notes: Meeting Abstract: 1548P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mrinal M Gounder
    230 Gounder